Vaxart Debt Ratio from 2010 to 2025

VXRT Stock

USD 0.52 0.05 8.77%

Vaxart Debt Ratio yearly trend continues to be comparatively stable with very little volatility. Debt Ratio will likely drop to 0.10 in 2025. From the period from 2010 to 2025, Vaxart Debt Ratio quarterly data regression had r-value of (0.01) and coefficient of variation of 355.60. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.10533148

Current Value

0.1

Quarterly Volatility

2.20860409

Credit Downgrade

Yuan Drop

Covid

Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Total Revenue of 27.3 M or Gross Profit of 19.8 M, as well as many indicators such as Price To Sales Ratio of 47.78, Dividend Yield of 0.0 or PTB Ratio of 23.85. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.

Check out the analysis of Vaxart Correlation against competitors.

Latest Vaxart's Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Vaxart Inc over the last few years. It is Vaxart's Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Vaxart Debt Ratio Regression Statistics

	Arithmetic Mean	0.62
	Geometric Mean	0.06
	Coefficient Of Variation	355.60
	Mean Deviation	1.03
	Median	0.06
	Standard Deviation	2.21
	Sample Variance	4.88
	Range	8.8915
	R-Value	(0.01)
	Mean Square Error	5.23
	R-Squared	0.000048
	Significance	0.98
	Slope	(0)
	Total Sum of Squares	73.17

Vaxart Debt Ratio History

	2024	0.11
	2023	0.29
	2022	0.14
	2021	0.0588
	2020	0.0472
	2019	0.0625
	2018	0.1

Other Fundumenentals of Vaxart Inc

Cash Flow To Debt Ratio

Vaxart Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Good Will	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Property Plant Equipment	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.91	-0.52	-0.59	0.09	0.56	0.88	0.23	0.06	0.18	-0.45	0.01	0.48	0.35	0.83	-0.23	0.61	-0.23	0.4	-0.04	0.57	-0.24	0.85	0.51	-0.5
Total Stockholder Equity	0.91		-0.72	-0.28	0.02	0.21	0.95	0.05	0.07	0.14	-0.33	-0.03	0.38	0.02	0.81	-0.24	0.4	-0.27	0.58	0.06	0.31	-0.25	0.87	0.76	-0.47
Net Debt	-0.52	-0.72		-0.26	0.04	0.24	-0.82	0.31	-0.03	0.02	-0.19	0.33	0.13	0.36	-0.48	0.2	0.09	0.17	-0.62	0.02	0.35	0.2	-0.45	-0.75	0.21
Retained Earnings	-0.59	-0.28	-0.26		-0.02	-0.86	-0.23	-0.72	0.04	-0.05	0.5	-0.14	-0.44	-0.64	-0.41	-0.01	-0.77	-0.04	0.25	0.11	-0.92	0.0	-0.42	0.2	0.37
Net Receivables	0.09	0.02	0.04	-0.02		0.24	0.05	-0.21	-0.4	0.31	0.11	-0.2	0.03	0.38	0.06	-0.25	-0.08	-0.59	0.25	0.31	0.11	-0.25	-0.31	-0.42	-0.03
Total Liab	0.56	0.21	0.24	-0.86	0.24		0.22	0.42	-0.02	0.17	-0.44	0.09	0.38	0.9	0.3	-0.07	0.7	-0.03	-0.2	-0.19	0.8	-0.07	0.31	-0.36	-0.28
Total Current Assets	0.88	0.95	-0.82	-0.23	0.05	0.22		-0.08	-0.06	0.12	-0.11	-0.18	0.33	0.03	0.71	-0.2	0.32	-0.24	0.56	0.0	0.19	-0.2	0.74	0.69	-0.47
Short Term Debt	0.23	0.05	0.31	-0.72	-0.21	0.42	-0.08		0.15	-0.12	-0.49	0.36	-0.02	0.24	0.38	-0.16	0.68	0.23	-0.36	-0.19	0.69	-0.17	0.28	-0.07	-0.3
Intangible Assets	0.06	0.07	-0.03	0.04	-0.4	-0.02	-0.06	0.15		-0.29	-0.66	-0.12	-0.34	-0.11	0.04	-0.13	-0.07	0.01	-0.07	-0.12	-0.05	-0.14	0.33	0.25	0.35
Accounts Payable	0.18	0.14	0.02	-0.05	0.31	0.17	0.12	-0.12	-0.29		-0.09	0.19	0.35	0.26	0.23	-0.19	0.12	-0.36	0.33	-0.14	0.29	-0.18	0.06	-0.04	-0.22
Common Stock	-0.45	-0.33	-0.19	0.5	0.11	-0.44	-0.11	-0.49	-0.66	-0.09		-0.19	-0.2	-0.32	-0.45	0.15	-0.41	0.27	-0.02	0.14	-0.63	0.17	-0.61	-0.17	0.0
Good Will	0.01	-0.03	0.33	-0.14	-0.2	0.09	-0.18	0.36	-0.12	0.19	-0.19		0.23	0.26	0.35	-0.15	0.6	0.48	-0.06	-0.19	0.32	-0.15	0.25	0.12	-0.24
Short Term Investments	0.48	0.38	0.13	-0.44	0.03	0.38	0.33	-0.02	-0.34	0.35	-0.2	0.23		0.28	0.29	0.16	0.37	-0.16	0.1	0.0	0.56	0.15	0.39	0.11	-0.39
Current Deferred Revenue	0.35	0.02	0.36	-0.64	0.38	0.9	0.03	0.24	-0.11	0.26	-0.32	0.26	0.28		0.18	-0.07	0.61	0.05	-0.23	-0.06	0.64	-0.07	0.14	-0.48	-0.21
Net Tangible Assets	0.83	0.81	-0.48	-0.41	0.06	0.3	0.71	0.38	0.04	0.23	-0.45	0.35	0.29	0.18		-0.47	0.67	-0.12	0.48	-0.08	0.5	-0.48	0.79	0.61	-0.46
Long Term Debt	-0.23	-0.24	0.2	-0.01	-0.25	-0.07	-0.2	-0.16	-0.13	-0.19	0.15	-0.15	0.16	-0.07	-0.47		-0.33	0.05	-0.16	-0.06	-0.1	1.0	-0.12	-0.17	0.0
Capital Surpluse	0.61	0.4	0.09	-0.77	-0.08	0.7	0.32	0.68	-0.07	0.12	-0.41	0.6	0.37	0.61	0.67	-0.33		0.35	-0.12	-0.19	0.79	-0.33	0.58	0.1	-0.45
Deferred Long Term Liab	-0.23	-0.27	0.17	-0.04	-0.59	-0.03	-0.24	0.23	0.01	-0.36	0.27	0.48	-0.16	0.05	-0.12	0.05	0.35		-0.53	0.0	-0.11	0.05	0.0	0.02	0.01
Long Term Investments	0.4	0.58	-0.62	0.25	0.25	-0.2	0.56	-0.36	-0.07	0.33	-0.02	-0.06	0.1	-0.23	0.48	-0.16	-0.12	-0.53		-0.12	-0.12	-0.16	0.35	0.51	-0.12
Short Long Term Debt	-0.04	0.06	0.02	0.11	0.31	-0.19	0.0	-0.19	-0.12	-0.14	0.14	-0.19	0.0	-0.06	-0.08	-0.06	-0.19	0.0	-0.12		-0.13	-0.06	-0.1	0.0	0.0
Property Plant Equipment	0.57	0.31	0.35	-0.92	0.11	0.8	0.19	0.69	-0.05	0.29	-0.63	0.32	0.56	0.64	0.5	-0.1	0.79	-0.11	-0.12	-0.13		-0.11	0.46	-0.16	-0.42
Long Term Debt Total	-0.24	-0.25	0.2	0.0	-0.25	-0.07	-0.2	-0.17	-0.14	-0.18	0.17	-0.15	0.15	-0.07	-0.48	1.0	-0.33	0.05	-0.16	-0.06	-0.11		-0.13	-0.17	0.0
Net Invested Capital	0.85	0.87	-0.45	-0.42	-0.31	0.31	0.74	0.28	0.33	0.06	-0.61	0.25	0.39	0.14	0.79	-0.12	0.58	0.0	0.35	-0.1	0.46	-0.13		0.74	-0.42
Net Working Capital	0.51	0.76	-0.75	0.2	-0.42	-0.36	0.69	-0.07	0.25	-0.04	-0.17	0.12	0.11	-0.48	0.61	-0.17	0.1	0.02	0.51	0.0	-0.16	-0.17	0.74		-0.25
Capital Stock	-0.5	-0.47	0.21	0.37	-0.03	-0.28	-0.47	-0.3	0.35	-0.22	0.0	-0.24	-0.39	-0.21	-0.46	0.0	-0.45	0.01	-0.12	0.0	-0.42	0.0	-0.42	-0.25

Click cells to compare fundamentals

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as Debt Ratio, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Debt Ratio	0.11	0.10
Cash Flow To Debt Ratio	(2.55)	(2.68)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vaxart Debt Ratio from 2010 to 2025

Latest Vaxart's Debt Ratio Growth Pattern

Vaxart Debt Ratio Regression Statistics

Vaxart Debt Ratio History

Other Fundumenentals of Vaxart Inc

Vaxart Debt Ratio component correlations

About Vaxart Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Vaxart Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY